Head-to-head · WeighScore
Contour Health vs HealthRX
The verdict
HealthRX takes it — 77.5/100 to 66.8/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Contour Health | HealthRX |
|---|---|---|
| WeighScore | 66.8/100 | 77.5/100 |
| Grade | C | C+ |
| Site position | #200 | #36 |
| Semaglutide | $160/mo (starting dose, compounded) | $149 first month, then $165/month; $1,163 per 12-month subscription |
| Tirzepatide | $300/mo (starting dose, compounded) | $193 first month, then $214/month; $2,123 per 12-month subscription |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #200 · C
Strengths
- Free medical consultation — no charge to talk with a provider before starting
- Pay-per-vial pricing with no long-term subscription commitment required to participate
- Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
- LegitScript badge links to a genuine, working LegitScript verification checker for the domain
- Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers
Where it loses points
- State availability list is not published — Terms of Service only says "certain states"
- All product purchases are non-refundable per Terms of Service
- Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
- Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
- No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only
Site position #36 · C+
Strengths
- Product pages publish due-today and next-charge tables
- Medication if approved, provider review and overnight shipping are included
- Longer plans offer a one-time purchase option without automatic renewal
Where it loses points
- Annual headline rates require payment for 12 months upfront
- Monthly subscription prices rise after the first payment
- Product navigation still shows older starting prices
- Injection supplies are not confirmed as standard inclusions
Featured provider
HealthRX
HealthRX scores 77.5/100 (C+). HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.